Market Cap 482.23M
Revenue (ttm) 292.50M
Net Income (ttm) -33.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.62%
Debt to Equity Ratio 0.00
Volume 797,000
Avg Vol 462,606
Day's Range N/A - N/A
Shares Out 41.08M
Stochastic %K 53%
Beta 0.78
Analysts Strong Sell
Price Target $19.00

Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy sy...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 518 795 1400
Address:
14 Plaza Drive, Latham, United States
DARKP00L
DARKP00L Oct. 3 at 2:21 PM
$ANGO 10:01 on Oct. 03 2025 Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $18 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 2:01 PM
Canaccord Genuity updates rating for AngioDynamics ( $ANGO ) to Buy, target set at 17 → 18.
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 12:27 PM
$ANGO posts a narrower-than-expected loss — bullish signs ahead? 🔍 💰 Adjusted loss per share of 10 cents beat the Zacks Consensus Estimate of 14 cents. 📈 Pro-forma revenue jumped 12.2% on a reported basis, with Med Tech sales increasing 26%. Discover what this means for ANGO's FY26 outlook here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-body-14575&ADID=SYND_STOCKTWITS_TWEET_2_2761304_BODY_14575
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 11:27 AM
$ANGO pops after Q1 surprise 🚀 Narrower-than-expected loss, 12% revenue growth, and improved margins — plus a raised FY26 sales outlook — lit a fire under the stock. Full breakdown here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-teaser-14574&ADID=SYND_STOCKTWITS_TWEET_2_2761304_TEASER_14574
0 · Reply
yjlkvui6762n
yjlkvui6762n Oct. 3 at 2:57 AM
$ANGO Why Did AngioDynamics Stock Pop Today? Even 37 years after its founding, AngioDynamics still can AngioDynamics beat earnings expectations this morning. The company achieved this not by earning more than expected, but by losing less than anticipated. However, full-year earnings are still projected to be negative.
0 · Reply
PermanentWave876
PermanentWave876 Oct. 3 at 12:28 AM
$ANGO Why Did AngioDynamics Stock Pop Today? Even 37 years after its founding, AngioDynamics still can AngioDynamics beat earnings estimates this morning. The company achieved this not by earning more than expected, but by losing less than anticipated. Full-year earnings will still be negative.
0 · Reply
RCheck
RCheck Oct. 2 at 5:49 PM
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 5:28 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $BTDR $KLAC $NP $ANGO 🚀
0 · Reply
RCheck
RCheck Oct. 2 at 3:09 PM
1 · Reply
RCheck
RCheck Oct. 2 at 3:03 PM
$ANGO Going back under 11 by tomorrow max!
0 · Reply
Latest News on ANGO
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript

Oct 2, 2025, 10:02 AM EDT - 2 days ago

AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript

Jul 15, 2025, 12:40 PM EDT - 2 months ago

AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript

Apr 2, 2025, 10:20 AM EDT - 6 months ago

AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript


AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 31, 2025, 8:00 AM EDT - 6 months ago

AngioDynamics to Host Virtual Cardiovascular Investor Event


AngioDynamics: A Surgical Approach To Market Growth

Jan 8, 2025, 5:15 PM EST - 9 months ago

AngioDynamics: A Surgical Approach To Market Growth


AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript

Jan 8, 2025, 11:00 AM EST - 9 months ago

AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

Oct 3, 2024, 10:29 AM EDT - 1 year ago

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript


AngioDynamics to Participate in Upcoming Investor Conferences

Jul 29, 2024, 4:15 PM EDT - 1 year ago

AngioDynamics to Participate in Upcoming Investor Conferences


AngioDynamics: Lumpy Progress Is Still Progress

Jul 17, 2024, 3:16 PM EDT - 1 year ago

AngioDynamics: Lumpy Progress Is Still Progress


AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript

Jul 16, 2024, 10:35 AM EDT - 1 year ago

AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript


A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 9, 2024, 4:49 PM EDT - 1 year ago

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story


AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript

Apr 4, 2024, 11:11 AM EDT - 1 year ago

AngioDynamics (ANGO) Q3 2024 Earnings Call Transcript


DARKP00L
DARKP00L Oct. 3 at 2:21 PM
$ANGO 10:01 on Oct. 03 2025 Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $18 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 2:01 PM
Canaccord Genuity updates rating for AngioDynamics ( $ANGO ) to Buy, target set at 17 → 18.
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 12:27 PM
$ANGO posts a narrower-than-expected loss — bullish signs ahead? 🔍 💰 Adjusted loss per share of 10 cents beat the Zacks Consensus Estimate of 14 cents. 📈 Pro-forma revenue jumped 12.2% on a reported basis, with Med Tech sales increasing 26%. Discover what this means for ANGO's FY26 outlook here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-body-14575&ADID=SYND_STOCKTWITS_TWEET_2_2761304_BODY_14575
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 11:27 AM
$ANGO pops after Q1 surprise 🚀 Narrower-than-expected loss, 12% revenue growth, and improved margins — plus a raised FY26 sales outlook — lit a fire under the stock. Full breakdown here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-teaser-14574&ADID=SYND_STOCKTWITS_TWEET_2_2761304_TEASER_14574
0 · Reply
yjlkvui6762n
yjlkvui6762n Oct. 3 at 2:57 AM
$ANGO Why Did AngioDynamics Stock Pop Today? Even 37 years after its founding, AngioDynamics still can AngioDynamics beat earnings expectations this morning. The company achieved this not by earning more than expected, but by losing less than anticipated. However, full-year earnings are still projected to be negative.
0 · Reply
PermanentWave876
PermanentWave876 Oct. 3 at 12:28 AM
$ANGO Why Did AngioDynamics Stock Pop Today? Even 37 years after its founding, AngioDynamics still can AngioDynamics beat earnings estimates this morning. The company achieved this not by earning more than expected, but by losing less than anticipated. Full-year earnings will still be negative.
0 · Reply
RCheck
RCheck Oct. 2 at 5:49 PM
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 5:28 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $BTDR $KLAC $NP $ANGO 🚀
0 · Reply
RCheck
RCheck Oct. 2 at 3:09 PM
1 · Reply
RCheck
RCheck Oct. 2 at 3:03 PM
$ANGO Going back under 11 by tomorrow max!
0 · Reply
topstockalerts
topstockalerts Oct. 2 at 2:05 PM
$ANGO heating up again.. Who’s ready for the next play to run??
0 · Reply
ChefPhil
ChefPhil Oct. 2 at 1:38 PM
$ANGO why mm drop it so fast. I don’t understand. All those buys. Why drop it down?
0 · Reply
EchoShift_43
EchoShift_43 Oct. 2 at 1:36 PM
$ANGO Growth phase just starting NXXT showed 19% y/y in 2024 Now over 200% y/y That’s scaling That’s demand That’s a trend
0 · Reply
topstockalerts
topstockalerts Oct. 2 at 1:32 PM
$ANGO sector heating up.. stay tuned!
0 · Reply
moh_iss
moh_iss Oct. 2 at 1:23 PM
$ANGO small float i like it
0 · Reply
moh_iss
moh_iss Oct. 2 at 1:18 PM
$ANGO so Fomo is needed here $BBAI $TLRY
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Oct. 2 at 1:07 PM
$ANGO https://www.investing.com/news/company-news/angiodynamics-q1-2026-slides-med-tech-surge-drives-122-revenue-growth-93CH-4268536
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 2 at 1:05 PM
$ANGO (+19.6% pre) AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum https://ooc.bz/l/79192
0 · Reply
DaBullRunner
DaBullRunner Oct. 2 at 1:05 PM
$ANGO there it goes…. ICU is going to make a big run soon 🚨🚨🚨🚨🚨 Here’s why👇
0 · Reply
GetVector
GetVector Oct. 2 at 12:53 PM
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $ANGO, $FICO, $TSHA.
0 · Reply
mikesterz7
mikesterz7 Oct. 2 at 12:52 PM
$ANGO Q1 fiscal year 2026 financial highlights Adjusted loss per share: 10 cents. This was better than the Zacks Consensus Estimate for a loss of 14 cents per share. Revenue: $75.7 million, which grew 12.2% compared to the same quarter the previous year and exceeded the analysts' consensus estimate. Net loss: $10.9 million, or 26 cents per share on a GAAP basis.
0 · Reply
topstockalerts
topstockalerts Oct. 2 at 12:12 PM
$ANGO look who’s up.. ⬆️
1 · Reply